| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,145 | 2,956 | 2,834 | 3,587 | | Cost of Revenue | 388 | 487 | 171 | 203 | | | Gross Profit | 4,757 | 2,470 | 2,663 | 3,384 | | | Operating Expenses | | Research Development | 4,939 | 5,325 | 5,219 | 6,302 | | Selling General and Administrative | 3,611 | 4,187 | 2,706 | 2,875 | | Non Recurring |
-
| (732) | 732 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,793) | (6,311) | (5,994) | (5,793) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (880) | (104) | 427 | 406 | | Earnings Before Interest And Taxes | (4,672) | (6,415) | (5,567) | (5,387) | | Interest Expense | 0 | 0 | 3 | 13 | | Income Before Tax | (4,673) | (6,415) | (5,570) | (5,400) | | Income Tax Expense |
-
|
-
|
-
| (962) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,673) | (6,415) | (5,570) | (4,438) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,673) | (6,415) | (5,570) | (4,438) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,673) | ($6,415) | ($5,570) | ($4,438) |
|
0.51% Nasdaq 
Income Statement
